b-AP15 is a small inhibitor of deubiquitinating enzymes USP14/UCHL5, and treatment with b-AP15 induces tumor regression and upregulates p27 protein level in tumors with p53 deficiency (Jiang et al., 2022). This evidence concerns the gene TP53 and neoplasm.